Forensic Genomics Market Size, Share & Trends Analysis Report By Product (Software, Consumables & Kits), By Method (NGS, PCR Amplification), By Application (Paternity & Familial, Criminal Testing), By Region, And Segment Forecasts, 2025 - 2030
Preclinical Medical Device Testing Services Market Growth & Trends
The global preclinical medical device testing services market size is expected to reach USD 6.55 billion by 2030, registering a CAGR of 9.20%, according to a new report by Grand View Research, Inc. The rising incidence of diseases has provided manufacturers with different approaches for the formation of medical devices and increasing demand for technologically advanced medical devices are the main factors driving the market growth.
The pace of technological advancement in the healthcare industry has vastly increased in recent years. Medical device technology advancements support simple, painless treatment during disease management. Additionally, advancements in medical device technology help with accurate and quick disease diagnosis results, as well as the affordability of technology-based therapeutic tools for disease treatment. Furthermore, numerous governmental agencies and healthcare institutions support medical research facilities. This funding is primarily intended to promote global health care innovations. The growth of medical device testing in the anticipated period is therefore supported by expanding innovation and technological advancement.
Preclinical testing plays a crucial role in the process of creating new products. Before beginning human testing, most of this testing has been completed and reports should be available. According to ISO-10993, biocompatibility testing results are needed to be included in 510(k) notifications for Class II equipment that has immediate patient contact or contact with the blood supply. This shows that the new device's risks are Please note The report will be delivered in 2-3 business days upon order notification.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Method Segment
- 1.2.3. Application Segment
- 1.3. Information Analysis
- 1.3.1. Market Formulation & Data Visualization
- 1.4. Data Validation & Publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.1.1. Rising Government Funds And Initiatives For Forensic Programs
- 3.3.1.2. Increasing Crime Rates
- 3.3.1.3. Technological Advancements In Paternity & Familial Testing
- 3.3.2. Market Restraint Analysis
- 3.3.2.1. High Cost Of Equipment
- 3.3.2.2. Lack Of Skilled Professionals In Developing Countries
- 3.4. Industry Analysis Tools
- 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
- 3.4.2. Porter’s Five Forces Analysis
- 3.4.3. COVID-19 Impact Analysis
- Chapter 4. Product Business Analysis
- 4.1. Product Segment Dashboard
- 4.2. Global Forensic Genomics Market: Product Movement Analysis
- 4.3. Global Forensic Genomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Analyzers & Sequencers
- 4.4.1. Analyzers & Sequencers Market, 2018 - 2030 (USD Million)
- 4.5. Software
- 4.5.1. Software Market, 2018 - 2030 (USD Million)
- 4.6. Kits & Consumables
- 4.6.1. Kits & Consumables Market, 2018 - 2030 (USD Million)
- Chapter 5. Method Business Analysis
- 5.1. Method Segment Dashboard
- 5.2. Global Forensic Genomics Market: Method Movement Analysis
- 5.3. Global Forensic Genomics Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
- 5.4. Capillary Electrophoresis
- 5.4.1. Capillary Electrophoresis Market, 2018 - 2030 (USD Million)
- 5.5. Next-generation Sequencing
- 5.5.1. Next-generation Sequencing Market, 2018 - 2030 (USD Million)
- 5.6. PCR Amplification
- 5.6.1. PCR Amplification Market, 2018 - 2030 (USD Million)
- 5.7. Others
- 5.7.1. Others Market, 2018 - 2030 (USD Million)
- Chapter 6. Application Business Analysis
- 6.1. Application Segment Dashboard
- 6.2. Global Forensic Genomics Market: Application Movement Analysis
- 6.3. Global Forensic Genomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 6.4. Criminal Testing
- 6.4.1. Criminal Testing Market, 2018 - 2030 (USD Million)
- 6.5. Paternity & Familial Testing
- 6.5.1. Paternity & Familial Testing Market, 2018 - 2030 (USD Million)
- 6.6. Others
- 6.6.1. Others Market, 2018 - 2030 (USD Million)
- Chapter 7. Regional Business Analysis
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. North America Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. U.S. Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Canada Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Mexico Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Germany Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.3. UK
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. UK Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. France Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Italy Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Spain Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Denmark Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Framework
- 7.4.8.4. Sweden Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Framework
- 7.4.9.4. Norway Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Japan Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. China Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. India Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. South Korea Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Australia Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Thailand Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Brazil Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Argentina Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. South Africa Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Saudi Arabia Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. UAE Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Kuwait Forensic Genomics Market, 2018 - 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2024
- 8.4. Participant’s Overview
- 8.4.1. Illumina, Inc.
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Thermo Fisher Scientific, Inc.
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Merck KGaA
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Agilent Technologies
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Promega Corporation
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. QIAGEN
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Bio-Rad Laboratories
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. LGC Limited
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Tri Tech Forensics
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Verogen
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook